Almujtama Alraida Medical Co. (9592.SR)
SAR 31.95
(2.4%)
SAR 31.95
(2.4%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | 68.14 Million | 18.53 Million | 17.27 Million |
| Net Income | 11.39 Million | 19.07 Million | 7.81 Million |
| Depreciation & Amortization | 29.46 Million | 22.03 Million | 23.78 Million |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | 21.2 Million | -32.01 Million | -17.9 Million |
| Other non-cash items | 51.11 Million | 86.23 Million | 56.71 Million |
| Investing Cash Flow | -40.29 Million | -19.58 Million | -7.32 Million |
| Investments in PPE | -40.39 Million | -19.58 Million | -7.32 Million |
| Acquisitions | 101.39 Thousand | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -40.29 Million | - | - |
| Financing Cash Flow | -18.9 Million | 877.97 Thousand | -9.83 Million |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | - | - |
| Other Financing Activities | 12 Million | 27.55 Million | 5.48 Million |
| Accounts receivables | -11.83 Million | 822.93 Thousand | -12.37 Million |
| Accounts payables | 30.01 Million | -24.71 Million | 36.29 Million |
| Inventory | -4.27 Million | -8.83 Million | -29.48 Million |
| Other working capital | 7.3 Million | 701.28 Thousand | -12.33 Million |
| Cash at beginning of period | 4.05 Million | 4.21 Million | 2.04 Million |
| Cash at end of period | 13 Million | 4.05 Million | 4.21 Million |
| Capital Expenditure | -40.39 Million | -19.58 Million | -7.32 Million |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 8.94 Million | -162.69 Thousand | 2.17 Million |
| Free Cash Flow | 27.74 Million | -1.04 Million | 9.94 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.98 Million | 11.39 Million | 60.47 Thousand | 11.33 Million | 12.23 Million | 19.07 Million |
| Depreciation & Amortization | 19.5 Million | 29.46 Million | 15.82 Million | 13.64 Million | 12.03 Million | 22.03 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.56 Million | 21.2 Million | 5.22 Million | 15.98 Million | -34.74 Million | -32.01 Million |
| Other non-cash items | 45.24 Million | 51.11 Million | 32.17 Million | 18.94 Million | 66.91 Million | 86.23 Million |
| Investing Cash Flow | -11.58 Million | -40.29 Million | -15.48 Million | -24.8 Million | -11.26 Million | -19.58 Million |
| Investments in PPE | -11.61 Million | -40.39 Million | -15.59 Million | -24.8 Million | -11.26 Million | -19.58 Million |
| Acquisitions | 39.19 Thousand | 101.39 Thousand | 101.39 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -18.41 Million | -18.9 Million | -1.86 Million | -17.04 Million | -7.29 Million | 877.97 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -18.41 Million | 12 Million | 13 Million | -1 Million | 8 Million | 27.55 Million |
| Accounts receivables | -842.33 Thousand | -11.83 Million | -2.77 Million | -9.05 Million | -4.4 Million | 822.93 Thousand |
| Accounts payables | 31.04 Million | 30.01 Million | 2.38 Million | 27.62 Million | -39.45 Million | -24.71 Million |
| Inventory | -31.1 Million | -4.27 Million | 1.72 Million | -6 Million | 6.32 Million | -8.83 Million |
| Other working capital | -1.66 Million | 7.3 Million | 3.89 Million | 3.41 Million | 2.78 Million | 701.28 Thousand |
| Cash at beginning of period | 13 Million | 4.05 Million | 7.39 Million | 4.05 Million | 27.76 Million | 4.21 Million |
| Cash at end of period | 7.26 Million | 13 Million | 13 Million | 7.39 Million | 4.05 Million | 4.05 Million |
| Capital Expenditure | -11.61 Million | -40.39 Million | -15.59 Million | -24.8 Million | -11.26 Million | -19.58 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.73 Million | 8.94 Million | 5.6 Million | 3.34 Million | -23.7 Million | -162.69 Thousand |
| Free Cash Flow | 12.64 Million | 27.74 Million | 7.36 Million | 20.38 Million | -16.41 Million | -1.04 Million |
CHIP
IBTA
4231
HLEE
TGR
PECN